Vitiligo
RecruitingStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
- Disease:Vitiligo
- Substances:Ruxolitinib
Bulgaria- Participants:0–17 years
- Substances:Ruxolitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to Bulgaria50 clinical trials in Sevlievo, Bulgaria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on respiratory viral infections and chronic conditions, evaluating new vaccines and treatments for improved patient outcomes.
Current trials are testing advanced vaccine formulations and novel therapeutic approaches for both acute and chronic respiratory conditions.
Comprehensive studies examining treatments for various skin disorders, from autoimmune conditions to chronic inflammatory diseases.
Research focuses on developing targeted therapies for improved symptom management and disease control.
Groundbreaking research into systemic autoimmune conditions, testing new biological treatments and therapeutic approaches.
Clinical trials are exploring innovative treatments to address both systemic and organ-specific manifestations of autoimmune diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.